Exactech, Inc. (EXAC)
The Company designs, manufactures, markets and distributes orthopaedic implant devices including knee, hip, shoulder and ankle joint replacement systems, bone allograft materials, surgical instrumentation, and bone cement and accessories.
Recs
kevinottofro
(98.71)
Submitted: 8/2/2009 8:10:39 AM :
Start Price:
$14.25
EXAC Score:
+3.64
Low relative PE, good star ranking, PEG & 09 PE still below normal - bottom fishing 7/27 picks (late getting them in this week).
Recs
surfacescrub
(53.96)
Submitted: 3/1/2009 10:06:06 PM :
Start Price:
$13.77
EXAC Score:
-36.56
Baby Boomers . . I work in PT and there is no shortage of these sorts of surgeries. There is also no end to the innovation in which joints can be replaced and how those components are made.
Recs
Rbbarn7ExicteCom
(81.92)
Submitted: 2/19/2009 12:37:00 PM :
Start Price:
$15.46
EXAC Score:
-37.18
POST BY RBBARN7EXCITECOM
MY BEST PICK
Recs
SuperCharge
(98.49)
Submitted: 2/14/2009 5:48:36 PM :
Start Price:
$14.49
EXAC Score:
-23.72
Recent quarterly earnings have fallen much less than the price of the stock. Aside from potential regulation, I'm bullish on orthopaedics for the mid-term but I'd be a lot more comfortable with this pick if there were insiders buying.
Recs
Recs
tixareforkids
(98.49)
Submitted: 7/16/2008 5:00:22 PM :
Start Price:
$31.11
EXAC Score:
-38.79
Planning for my future in more than one way...
Recs
emarw
(69.37)
Submitted: 7/16/2008 3:02:38 PM :
Start Price:
$30.94
EXAC Score:
-39.55
Turning grey to green. Gotta love that.
Recs
AHavoc
(< 20)
Submitted: 7/2/2008 8:16:27 PM :
Start Price:
$27.93
EXAC Score:
-31.38
Institutional investors are driving up volume; quarterlies, eps, good; new technology, known by surgeons as "leader"; demand for product will grow with aging population; earmarks of a healthy stock opportunity.
Recs
shekoe
(23.62)
Submitted: 6/20/2008 8:41:20 AM :
Start Price:
$26.19
EXAC Score:
-23.47
Another play on the graying of America. It makes artificial knees, etc. Also involved with innovative substances that stimulate cartilage growth. Might be "cure" for arthritis. PE is 33, sales growing rapidly.
Recs
bbubbba
(< 20)
Submitted: 5/9/2008 10:43:18 PM :
Start Price:
$24.30
EXAC Score:
-15.09
Solid growth!
Recs
vjdantone
(81.13)
Submitted: 4/25/2008 9:33:42 AM :
Start Price:
$25.99
EXAC Score:
-19.47
I'm down on my knees for this stock.....as the boomers age and need more body parts.....
Recs
lb1951
(54.97)
Submitted: 3/5/2008 8:53:22 PM :
Start Price:
$27.41
EXAC Score:
+27.13
Has had a great 12 months --time to consolidate
Recs
munypro
(< 20)
Submitted: 1/20/2008 3:22:25 PM :
Start Price:
$22.00
EXAC Score:
-16.29
With the babyboomers becoming retirees and they being one of the fasters growing portions of the population, it only stands to reason that this companies products will be in high demand.
Recs
poconnor3
(34.91)
Submitted: 1/18/2008 11:02:02 PM :
Start Price:
$22.00
EXAC Score:
-16.29
it remained strong during a period of downturns
& disasters because it's product is oriented toward the future of business.
Recs
YellowBill
(< 20)
Submitted: 1/10/2008 3:29:24 PM :
Start Price:
$22.23
EXAC Score:
-7.17
Boomers are getting older. Demand for Exactech products grows at a steady rate as Boomers age.
Recs
lareineivre
(91.56)
Submitted: 12/30/2007 2:48:23 AM :
Start Price:
$20.83
EXAC Score:
+0.25
Favorable risk / reward profile. Comparative analysis:
http://f1.grp.yahoofs.com/v1/8EF3R8IApDlbI1SUEwj9ACPoO-N506V3BymU7tTVdt21_4PxNLCn-oJ6KY_K8iQ5Z-yn652fM-b9S1MpHcVrFg/VOps/VOps%2007.11.30.xls
Recs
JCash22
(87.59)
Submitted: 12/1/2007 3:46:21 AM :
Start Price:
$19.17
EXAC Score:
+7.28
As we get older, so do our bones.
Recs
PIcolano
(22.06)
Submitted: 11/6/2007 12:06:00 PM :
Start Price:
$21.66
EXAC Score:
-1.47
Interesting metrics - let's see where it goes...
Recs
johnnymack91362
(71.24)
Submitted: 10/30/2007 1:58:11 PM :
Start Price:
$17.85
EXAC Score:
+16.42
medical implants for knees,hips and shoulders. nice revenue trajectory.
Recs
StockBoxChandler
(< 20)
Submitted: 10/7/2007 2:05:06 PM :
Start Price:
$15.75
EXAC Score:
+27.90
Currently there are 500,000 knee operations per year in the United States. In 25 years that number is expected to grow to 3,000,000. Exactech is a orthopedic implant manufacturer that is well positioned to take advantage of such growth. Granted there are big players in the market such as Biomet, Stryker and Johnson & Johnson, but with 41 percent insider ownership and an increasingly strong sales force and product pipeline Exactech is well positioned to compete on the largest stage. Currently, Exactech is cheaply priced compared to much larger competitors that don't share Exactech's growth prospects. Also, with just a 180 million dollar market cap, very few analysts and institutions follow Exactech. As the company grows increases in analyst following could buoy the stock price further bring better returns to Exactech's shareholders.
Here is some pretty good research on Exactech: http://stockboxfinancial.com/stockbox_picks/stockboxpick_exac.pdf
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 22 1 2 Next »